Programmed cell death (apoptosis) is a basic biological process used to modify cell repertoires during development, and also involved in cancer, anti-neoplastic therapy, and AIDS. The antigen-specific repertoire of lymphocytes is established through processes of apoptosis, rescue from apoptosis, and proliferation. Signals triggered by the engagement of antigen-specific receptors on lymphocytes are crucial for these processes. These signals guide the development of immature lymphocytes and also control mature T cells. Much less is known about the mechanisms which connect T cell receptor (TCR)-derived signals to apoptosis than about the cellular interactions which guide repertoire formation in the thymus and T cell activation in the periphery. Our long-term goal is to understand the pathways which link cell surface-derived signals with apoptosis of thymocytes. The theme of this proposal is that biochemical and molecular biologic investigations into the genes which connect cell surface-derived signals to apoptosis will be facilitated by the development of a genetic approach to studying these pathways. We have identified a thymic lymphoma cell line which resembles immature thymocytes and which undergoes apoptosis as a result of TCR cross-linking or lectin treatment, and an immature thymocyte lymphoma of known TCR specificity which undergoes negative selection in response to physiologic TCR engagement by antigen with major histocompatibility complex (MHC) protein. Following insertional mutagenesis with a gene-trap retrovirus and selection by lectin treatment, we have generated a panel of apoptosis-resistant mutants. Since mutations created by gene-trap retroviruses are tagged by the virus the process of identifying mutant genes is accelerated compared to other methods of mutagenesis.
Our specific aims are to characterize mutations which lead to resistance to apoptosis in thymocyte mutants already selected after gene- trap mutagenesis. We also propose to improve this technology, using the thymocyte cell line of known T cell receptor specificity. Apoptosis- resistant thymocyte mutants represent unique reagents which ultimately will be used to investigate the order of gene action along pathways between the TCR and cell death.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI036997-01A1
Application #
2073570
Study Section
Immunobiology Study Section (IMB)
Project Start
1995-08-01
Project End
1999-07-31
Budget Start
1995-08-01
Budget End
1996-07-31
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Corn, Radiah A; Aronica, Mark A; Zhang, Fuping et al. (2003) T cell-intrinsic requirement for NF-kappa B induction in postdifferentiation IFN-gamma production and clonal expansion in a Th1 response. J Immunol 171:1816-24
Mora, A L; Corn, R A; Stanic, A K et al. (2003) Antiapoptotic function of NF-kappaB in T lymphocytes is influenced by their differentiation status: roles of Fas, c-FLIP, and Bcl-xL. Cell Death Differ 10:1032-44
Mora, A L; Stanley, S; Armistead, W et al. (2001) Inefficient ZAP-70 phosphorylation and decreased thymic selection in vivo result from inhibition of NF-kappaB/Rel. J Immunol 167:5628-35
Boothby, M; Mora, A L; Stephenson, L M (2001) Lymphokine-dependent proliferation of T-lymphoid cells: regulated responsiveness and role in vivo. Crit Rev Immunol 21:487-522
Mora, A; Youn, J; Keegan, A et al. (2001) NF-kappa B/Rel participation in the lymphokine-dependent proliferation of T lymphoid cells. J Immunol 166:2218-27
Aronica, M A; Goenka, S; Boothby, M (2000) IL-4-dependent induction of BCL-2 and BCL-X(L)IN activated T lymphocytes through a STAT6- and pi 3-kinase-independent pathway. Cytokine 12:578-87
Mora, A L; Chen, D; Boothby, M et al. (1999) Lineage-specific differences among CD8+ T cells in their dependence of NF-kappa B/Rel signaling. Eur J Immunol 29:2968-80
Aune, T M; Mora, A L; Kim, S et al. (1999) Costimulation reverses the defect in IL-2 but not effector cytokine production by T cells with impaired IkappaBalpha degradation. J Immunol 162:5805-12
Aronica, M A; Mora, A L; Mitchell, D B et al. (1999) Preferential role for NF-kappa B/Rel signaling in the type 1 but not type 2 T cell-dependent immune response in vivo. J Immunol 163:5116-24
Seetharaman, R; Mora, A L; Nabozny, G et al. (1999) Essential role of T cell NF-kappa B activation in collagen-induced arthritis. J Immunol 163:1577-83

Showing the most recent 10 out of 13 publications